Johnson & Johnson Innovation - JJDC, Inc. 4/A

Accession 0000950170-24-010710

CIK 0001235912other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:47 PM ET

Size

41.6 KB

Accession

0000950170-24-010710

Insider Transaction Report

Form 4/AAmended

Period: 2023-09-15

CVRx, Inc.CVRX

Johnson & Johnson Innovation - JJDC, Inc.

10% Owner

Transactions

Other
Stock Option (Right to Buy)
2023-09-15−237→ 0 total
Exercise: $0.24Exp: 2023-12-14→ Common Stock (237 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−1,264→ 0 total
Exercise: $5.14Exp: 2031-01-04→ Common Stock (1,264 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−158→ 0 total
Exercise: $0.24Exp: 2024-11-18→ Common Stock (158 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−189→ 0 total
Exercise: $0.24Exp: 2025-08-06→ Common Stock (189 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−165→ 0 total
Exercise: $0.24Exp: 2025-08-06→ Common Stock (165 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−118→ 0 total
Exercise: $0.24Exp: 2025-08-06→ Common Stock (118 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−71→ 0 total
Exercise: $0.24Exp: 2025-08-06→ Common Stock (71 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−23→ 0 total
Exercise: $0.24Exp: 2025-08-06→ Common Stock (23 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−85→ 0 total
Exercise: $0.24Exp: 2025-11-09→ Common Stock (85 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−758→ 0 total
Exercise: $0.24Exp: 2027-02-01→ Common Stock (758 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−489→ 0 total
Exercise: $0.24Exp: 2027-02-01→ Common Stock (489 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−758→ 0 total
Exercise: $0.24Exp: 2028-02-15→ Common Stock (758 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−300→ 0 total
Exercise: $0.24Exp: 2028-02-15→ Common Stock (300 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−758→ 0 total
Exercise: $1.19Exp: 2028-11-28→ Common Stock (758 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−142→ 0 total
Exercise: $1.19Exp: 2028-11-28→ Common Stock (142 underlying)
Other
Stock Option (Right to Buy)
2023-09-15−758→ 0 total
Exercise: $3.96Exp: 2029-12-05→ Common Stock (758 underlying)

Footnotes (5)

[F1]This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law,
[F2](Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein.
[F3]Fully vested.
[F4]Vests as to 1/48th of the shares each month commencing January 6, 2020.
[F5]Vests as to 1/48th of the shares each month commencing January 11, 2021.

Documents

1 file

4
ownership.xml
4/A

Issuer

CVRx, Inc.

CIK 0001235912

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0000924020

Filing Metadata

Form type: 4/A
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 5:47 PM ET
Size: 41.6 KB

View on SEC.gov